← Dashboard

Compliance Alert: Camzyos

Configure Methodology
62
Caution

Camzyos scores 62/100 (Caution) based on analysis of 60s promotional content. 2 enforcement patterns detected across Visual Distraction — “Outdoor & Physical Activity” identified at 25.3s, previously cited in BRUKINSA, COBENFY, Fasenra (x3). FDA enforcement letter on file dated Sep 9, 2025. Weakest dimension: Content Lifecycle at 38/100.

Camzyos | Bristol Myers Squibb | Dtc Broadcast
FDA Letter DOC-2025-001239 Mar 7, 2026

Patterns Detected (2)

Matched against 14 enforcement patterns from 42 FDA letters

Visual Distraction
Outdoor & Physical Activity
Risk information must be presented in a clear, conspicuous, and neutral manner without distracting visuals
38
25.3s – 33.4s
33.4s – 39.6s
FDA Precedent: BRUKINSA, COBENFY, Fasenra (x3), Velsipity, Calquence 21 CFR 202.1(e)(1)
Visual Distraction
Family & Social Scenes
Risk information must be presented in a clear, conspicuous, and neutral manner without distracting visuals
38
19.7s – 25.3s
33.4s – 39.6s
39.6s – 60.0s
FDA Precedent: Jardiance (x3), Contrave, Qulipta, Calquence, Austedo (x2) 21 CFR 202.1(e)(1)
62
Master
38
Visual
30%
75
Efficacy
25%
83
Fair Balance
20%
75
Adeq Prov
15%
38
Lifecycle
10%
Safety Information Window
Risk disclosure: 25.1s – 50.0s (25.0s of 60.3s total — 41.4% of ad)
19.7s — Family Social
25.3s — Outdoor Physical
33.4s — Family Social+Vd Outdoor Physical
39.6s — Family Social
0s60s
!
FDA Enforcement Action on File
FDA Letter Sep 9, 2025 View PDF →

Visual Evidence (4 clips)

19.7s – 25.3s Family Social
25.3s – 33.4s Outdoor Physical
33.4s – 39.6s Family Social, Outdoor Physical
39.6s – 60.0s Family Social

Recommendations

high
Flag for next MLR cycle: Visual content during safety information window (25s–50s) may distract from risk disclosure. Schedule creative revision to use static or neutral visuals during major statement.
medium
Initiate PromoMats review: Content lifecycle dates approaching. Verify talent/music rights expiration and confirm claims substantiation against current data.
high
Escalate to regulatory affairs: FDA enforcement letter on file (Sep 9, 2025). Verify remediation status in PromoMats and confirm all content modifications address cited violations before next distribution.
Veeva PromoMats Details
Document ID
DOC-2025-001239
Status
Approved for Distribution
Version
1.0
Content Type
Dtc Broadcast
MLR Review
Feb 28, 2025
Next Review Due
Feb 1, 2026 (Expired)
Talent Expiration
Feb 15, 2026 (Expired)
Music License
Aug 1, 2026 (71d)

Powered by cQuenced